Microbicidal topical vaginal agents for chlamydia/gonorrhea is first topic for FDA cmte..
This article was originally published in The Tan Sheet
Executive Summary
MICROBICIDAL TOPICAL VAGINAL AGENTS FOR CHLAMYDIA AND GONORRHEA will be the first topic of discussion at FDA's joint advisory committee meeting on spermicides Nov. 20-22 at the Holiday Inn in Gaithersburg, Md. The first day will open with committee discussion on the use of microbicidal topical vaginal agents in prevention of sexual transmission of chlamydia and gonorrhea, according to an Oct. 30 Federal Register notice. The three-day meeting will bring together FDA's Nonprescription, Antiviral, Anti-infective and Reproductive Health Drugs Advisory Committees.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: